Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study

Authors: Kaku A Armah, Emily K Quinn, Debbie M Cheng, Russell P Tracy, Jason V Baker, Jeffrey H Samet, Matthew S Freiberg

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Assessing whether hepatitis C (HCV) co-infection with human immunodeficiency virus (HIV) is associated with increased inflammation is complex. The liver, integral to inflammatory biomarker synthesis, is compromised by HCV and alcohol abuse. Using single liver-synthesized biomarkers (e.g. C-reactive protein) to represent inflammation may not be appropriate in HIV/HCV co-infection. We hypothesized that 1) detectable HIV/HCV RNA was independently associated with increased inflammation; 2) a composite inflammation measure describes inflammation differently from single inflammatory biomarkers.

Methods

We compared inflammation by HIV/HCV group in a cohort of 361 HIV infected participants from the HIV-Longitudinal Interrelationships of Viruses and Ethanol study. Inflammatory biomarkers >75th percentile were considered elevated. Associations between HIV/HCV group and elevated biomarkers were analyzed as a composite measure (inflammatory burden) or individually. We defined inflammatory burden as number of concurrently elevated biomarkers. Biomarkers included interleukin-6 (IL-6), C-reactive protein (CRP), cystatin C, serum amyloid-A (SAA), tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10). Covariates: alcohol, liver fibrosis, comorbidities, CD4 count, antiretroviral therapy, substance use.

Results

Detectable HIV and HCV RNA (OR = 2.49; 95% CI = 1.05–5.89) and detectable HCV RNA alone (2.95; 1.08–8.01) were independently associated with increased odds of having a greater inflammatory burden compared to undetectable viremia. Elevated IL-10 (7.79; 1.90–31.97) and TNF-α (7.70; 1.42–41.83) were independently associated with detectable HIV and HCV RNA. Elevated IL-10 was also associated with detectable HCV RNA alone (5.51; 1.17, 25.84).

Conclusions

Detectable HIV and HCV replication versus undetectable replication was associated with inflammatory burden and certain inflammatory biomarkers independently of alcohol consumption, liver fibrosis and other comorbidities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Rodriguez Barradas MC, et al: The risk of incident coronary heart disease among veterans with and without HIV and Hepatitis C. Circ Cardiovasc Qual Outcomes. 2011, 4 (4): 425-432. 10.1161/CIRCOUTCOMES.110.957415.CrossRefPubMedPubMedCentral Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Rodriguez Barradas MC, et al: The risk of incident coronary heart disease among veterans with and without HIV and Hepatitis C. Circ Cardiovasc Qual Outcomes. 2011, 4 (4): 425-432. 10.1161/CIRCOUTCOMES.110.957415.CrossRefPubMedPubMedCentral
2.
go back to reference Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M: Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010, 11 (7): 462-468.PubMed Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M: Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010, 11 (7): 462-468.PubMed
3.
go back to reference Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC: Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009, 49 (2): 225-232. 10.1086/599371.CrossRefPubMedPubMedCentral Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC: Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009, 49 (2): 225-232. 10.1086/599371.CrossRefPubMedPubMedCentral
4.
go back to reference Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH: The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS. 2007, 21 (2): 193-197. 10.1097/QAD.0b013e3280118a0d.CrossRefPubMedPubMedCentral Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH: The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS. 2007, 21 (2): 193-197. 10.1097/QAD.0b013e3280118a0d.CrossRefPubMedPubMedCentral
5.
go back to reference Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA, Rodriguez-Barradas MC, et al: Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis. 2012, 54 (7): 984-994. 10.1093/cid/cir989.CrossRefPubMedPubMedCentral Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA, Rodriguez-Barradas MC, et al: Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis. 2012, 54 (7): 984-994. 10.1093/cid/cir989.CrossRefPubMedPubMedCentral
6.
go back to reference Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al: Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011, 203 (6): 780-790. 10.1093/infdis/jiq118.CrossRefPubMedPubMedCentral Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, et al: Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011, 203 (6): 780-790. 10.1093/infdis/jiq118.CrossRefPubMedPubMedCentral
7.
go back to reference Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I: Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010, 24 (10): 1509-1517. 10.1097/QAD.0b013e32833ad914.CrossRefPubMedPubMedCentral Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I: Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010, 24 (10): 1509-1517. 10.1097/QAD.0b013e32833ad914.CrossRefPubMedPubMedCentral
8.
go back to reference Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, et al: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008, 5 (10): e203-10.1371/journal.pmed.0050203.CrossRefPubMedPubMedCentral Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, et al: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008, 5 (10): e203-10.1371/journal.pmed.0050203.CrossRefPubMedPubMedCentral
9.
go back to reference Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R: Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007, 46 (2): 194-199. 10.1097/QAI.0b013e318142aabb.CrossRefPubMedPubMedCentral Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R: Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007, 46 (2): 194-199. 10.1097/QAI.0b013e318142aabb.CrossRefPubMedPubMedCentral
10.
go back to reference Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA: Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004, 20 (2): 151-155. 10.1089/088922204773004860.CrossRefPubMed Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA: Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004, 20 (2): 151-155. 10.1089/088922204773004860.CrossRefPubMed
11.
go back to reference Smith KL, Horton NJ, Saitz R, Samet JH: The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend. 2006, 82 (3): 231-237. 10.1016/j.drugalcdep.2005.09.012.CrossRefPubMed Smith KL, Horton NJ, Saitz R, Samet JH: The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend. 2006, 82 (3): 231-237. 10.1016/j.drugalcdep.2005.09.012.CrossRefPubMed
12.
go back to reference Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, Goetz M, Tracy R, Oursler KK, Rimland D, et al: HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012, 55 (1): 126-136. 10.1093/cid/cis406.CrossRefPubMedPubMedCentral Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, Goetz M, Tracy R, Oursler KK, Rimland D, et al: HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012, 55 (1): 126-136. 10.1093/cid/cis406.CrossRefPubMedPubMedCentral
13.
go back to reference Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101 (15): 1767-1772. 10.1161/01.CIR.101.15.1767.CrossRefPubMed Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101 (15): 1767-1772. 10.1161/01.CIR.101.15.1767.CrossRefPubMed
14.
go back to reference Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000, 342 (12): 836-843. 10.1056/NEJM200003233421202.CrossRefPubMed Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000, 342 (12): 836-843. 10.1056/NEJM200003233421202.CrossRefPubMed
15.
go back to reference Kuller LH, Tracy RP, Shaten J, Meilahn EN: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996, 144 (6): 537-547.CrossRefPubMed Kuller LH, Tracy RP, Shaten J, Meilahn EN: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996, 144 (6): 537-547.CrossRefPubMed
16.
go back to reference Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998, 394 (6696): 894-897. 10.1038/29788.CrossRefPubMed Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998, 394 (6696): 894-897. 10.1038/29788.CrossRefPubMed
17.
go back to reference Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN: Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009, 200 (6): 973-983. 10.1086/605447.CrossRefPubMedPubMedCentral Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN: Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009, 200 (6): 973-983. 10.1086/605447.CrossRefPubMedPubMedCentral
18.
go back to reference Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, et al: Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010, 201 (12): 1788-1795. 10.1086/652749.CrossRefPubMedPubMedCentral Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, et al: Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010, 201 (12): 1788-1795. 10.1086/652749.CrossRefPubMedPubMedCentral
19.
go back to reference Hurlimann J, Thorbecke GJ, Hochwald GM: The liver as the site of C-reactive protein formation. J Exp Med. 1966, 123 (2): 365-378. 10.1084/jem.123.2.365.CrossRefPubMedPubMedCentral Hurlimann J, Thorbecke GJ, Hochwald GM: The liver as the site of C-reactive protein formation. J Exp Med. 1966, 123 (2): 365-378. 10.1084/jem.123.2.365.CrossRefPubMedPubMedCentral
20.
go back to reference Morrow JF, Stearman RS, Peltzman CG, Potter DA: Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA. 1981, 78 (8): 4718-4722. 10.1073/pnas.78.8.4718.CrossRefPubMedPubMedCentral Morrow JF, Stearman RS, Peltzman CG, Potter DA: Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA. 1981, 78 (8): 4718-4722. 10.1073/pnas.78.8.4718.CrossRefPubMedPubMedCentral
21.
go back to reference Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, et al: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 8 (5): 446-454. 10.1097/00042560-199504120-00003.CrossRefPubMed Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, et al: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 8 (5): 446-454. 10.1097/00042560-199504120-00003.CrossRefPubMed
22.
go back to reference Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL: Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000, 38 (2): 575-577.PubMedPubMedCentral Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL: Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000, 38 (2): 575-577.PubMedPubMedCentral
23.
go back to reference Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, SS M, Torriani FJ, Dieterich DT, Thomas DL, et al: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006, 43 (6): 1317-1325. 10.1002/hep.21178.CrossRefPubMed Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, SS M, Torriani FJ, Dieterich DT, Thomas DL, et al: Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006, 43 (6): 1317-1325. 10.1002/hep.21178.CrossRefPubMed
24.
go back to reference Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E: The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addict Behav. 1986, 11 (2): 149-161. 10.1016/0306-4603(86)90040-7.CrossRefPubMed Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E: The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addict Behav. 1986, 11 (2): 149-161. 10.1016/0306-4603(86)90040-7.CrossRefPubMed
26.
go back to reference Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH: Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Res Hum Retroviruses. 2013, 29 (8): 1110-1116. 10.1089/aid.2012.0348.CrossRefPubMedPubMedCentral Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, Freiberg MS, Samet JH: Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Res Hum Retroviruses. 2013, 29 (8): 1110-1116. 10.1089/aid.2012.0348.CrossRefPubMedPubMedCentral
27.
go back to reference Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT: Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res. 2007, 27 (4): 263-269. 10.1089/jir.2006.0147.CrossRefPubMedPubMedCentral Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT: Viral factors associated with cytokine expression during HCV/HIV co-infection. J Interferon Cytokine Res. 2007, 27 (4): 263-269. 10.1089/jir.2006.0147.CrossRefPubMedPubMedCentral
28.
go back to reference El-Hage N, Dever SM, Fitting S, Ahmed T, Hauser KF: HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses. J Virol. 2011, 85 (22): 11601-11614. 10.1128/JVI.05239-11.CrossRefPubMedPubMedCentral El-Hage N, Dever SM, Fitting S, Ahmed T, Hauser KF: HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses. J Virol. 2011, 85 (22): 11601-11614. 10.1128/JVI.05239-11.CrossRefPubMedPubMedCentral
29.
go back to reference Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ: Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology. 2004, 40 (1): 125-132. 10.1002/hep.20258.CrossRefPubMed Graham CS, Curry M, He Q, Afdhal N, Nunes D, Fleming C, Horsburgh R, Craven D, Sherman KE, Koziel MJ: Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology. 2004, 40 (1): 125-132. 10.1002/hep.20258.CrossRefPubMed
30.
go back to reference Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccala G, Chung RT: Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006, 78 (2): 202-207. 10.1002/jmv.20528.CrossRefPubMed Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccala G, Chung RT: Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006, 78 (2): 202-207. 10.1002/jmv.20528.CrossRefPubMed
31.
go back to reference Floris-Moore M, Howard AA, Lo Y, Schoenbaum EE, Arnsten JH, Klein RS: Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS. 2007, 21 (7): 479-491. 10.1089/apc.2006.0150.CrossRefPubMedPubMedCentral Floris-Moore M, Howard AA, Lo Y, Schoenbaum EE, Arnsten JH, Klein RS: Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS. 2007, 21 (7): 479-491. 10.1089/apc.2006.0150.CrossRefPubMedPubMedCentral
32.
go back to reference Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, et al: Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr. 2008, 48 (2): 142-148. 10.1097/QAI.0b013e3181685727.CrossRefPubMedPubMedCentral Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, et al: Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr. 2008, 48 (2): 142-148. 10.1097/QAI.0b013e3181685727.CrossRefPubMedPubMedCentral
33.
go back to reference Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M: Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol. 2008, 9: 28-10.1186/1471-2172-9-28.CrossRefPubMedPubMedCentral Barrett L, Gallant M, Howley C, Bowmer MI, Hirsch G, Peltekian K, Grant M: Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol. 2008, 9: 28-10.1186/1471-2172-9-28.CrossRefPubMedPubMedCentral
34.
go back to reference Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Keller F: Production of cytokines in patients infected by hepatitis C virus. J Med Virol. 1998, 55 (2): 89-91. 10.1002/(SICI)1096-9071(199806)55:2<89::AID-JMV1>3.0.CO;2-J.CrossRefPubMed Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Keller F: Production of cytokines in patients infected by hepatitis C virus. J Med Virol. 1998, 55 (2): 89-91. 10.1002/(SICI)1096-9071(199806)55:2<89::AID-JMV1>3.0.CO;2-J.CrossRefPubMed
35.
go back to reference Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R: Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int. 2009, 29 (8): 1158-1161. 10.1111/j.1478-3231.2009.02052.x.CrossRefPubMed Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R: Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int. 2009, 29 (8): 1158-1161. 10.1111/j.1478-3231.2009.02052.x.CrossRefPubMed
36.
go back to reference Gonzalez SA, Zhang C, Fiel MI, Chung S, Zhang L, Jacobson IM, Talal AH: Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection. J Viral Hepat. 2008, 15 (5): 331-338. 10.1111/j.1365-2893.2007.00949.x.CrossRefPubMed Gonzalez SA, Zhang C, Fiel MI, Chung S, Zhang L, Jacobson IM, Talal AH: Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection. J Viral Hepat. 2008, 15 (5): 331-338. 10.1111/j.1365-2893.2007.00949.x.CrossRefPubMed
37.
go back to reference Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006, 12 (11): 1301-1309. 10.1038/nm1492.CrossRefPubMedPubMedCentral Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB: Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006, 12 (11): 1301-1309. 10.1038/nm1492.CrossRefPubMedPubMedCentral
38.
go back to reference Baker J, Ayenew W, Quick H, Hullsiek KH, Tracy R, Henry K, Duprez D, Neaton JD: High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis. 2010, 201 (2): 285-292. 10.1086/649560.CrossRefPubMedPubMedCentral Baker J, Ayenew W, Quick H, Hullsiek KH, Tracy R, Henry K, Duprez D, Neaton JD: High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis. 2010, 201 (2): 285-292. 10.1086/649560.CrossRefPubMedPubMedCentral
39.
go back to reference Nunez M: Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006, 44 (1 Suppl): S132-139.CrossRefPubMed Nunez M: Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006, 44 (1 Suppl): S132-139.CrossRefPubMed
40.
go back to reference Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed
Metadata
Title
Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study
Authors
Kaku A Armah
Emily K Quinn
Debbie M Cheng
Russell P Tracy
Jason V Baker
Jeffrey H Samet
Matthew S Freiberg
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-399

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.